End to End Connectivity Consultant Project

Consultant to identify gaps and needs among biopharmaceutical manufacturing industry members in the focus area of End-to-End Connectivity. The result will influence the Big Data Program FY27 End-to-End Connectivity project.
Categories
Process control
Data

Industry Need

In this capacity, the consultant will 1) receive and clarify information from NIIMBL pertaining to the “industry needs”, 2) identify “solutions” and published evidence which address the needs, 3) analyze “need / solution pairs” using a interoperability conceptual framework to document gaps and challenges, 4) document and deliver solution challenges, and gaps findings to the Big-Data Program / Interoperability Workstream within the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

Approach

In this capacity, the consultant will 1) receive information from NIIMBL members pertaining to the “industry needs”, 2) identify “solutions” with published evidence which address the needs, 3) analyze “need / solution pairs” using a interoperability conceptual framework to document gaps and challenges, 4) document and deliver solution(s), challenges, and gaps findings to the Big-Data Program / Interoperability Workstream within the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

Value Statement/Outcomes

This initiative maximizes ROI by eliminating the high costs of redundant development, potentially reducing engineering overhead by 20–30% and ensuring industry members leverage existing global standards rather than investing in expensive, custom-built data silos.

By resolving interoperability gaps now, our accelerated technology transfers by up to 40% and improve speed-to-market by 3–6 months through seamless, standardized data exchange across our global manufacturing network.

Ultimately, this project provides the foundational architecture required to scale high-value AI and Big Data analytics, transforming raw bioprocessing information into a streamlined enterprise asset that can drive a 15–25% increase in operational throughput.

Additional Project Information (Members Only)

Login to the NIIMBL member portal to access additional project information, including presentations, progress updates, reports, and more.

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Participating Organizations

Agilent

Agilent

Boehringer Ingelheim

Boehringer Ingelheim

EMD Millipore Corporation

EMD Millipore Corporation

North Carolina State University

North Carolina State University

Pfizer, Inc.

Pfizer, Inc.